Pacific Biosciences of California Inc (PACB)
1.46
+0.06
(+4.29%)
USD |
NASDAQ |
Apr 18, 16:00
1.43
-0.03
(-2.05%)
After-Hours: 05:24
Pacific Biosciences of California Debt to Equity Ratio: 1.273 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.273 |
| September 30, 2023 | 1.168 |
| June 30, 2023 | 1.389 |
| March 31, 2023 | 1.296 |
| December 31, 2022 | 1.596 |
| September 30, 2022 | 1.431 |
| June 30, 2022 | 1.315 |
| March 31, 2022 | 1.22 |
| December 31, 2021 | 1.135 |
| September 30, 2021 | 1.066 |
| June 30, 2021 | 3.469 |
| March 31, 2021 | 3.192 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.289 |
| September 30, 2019 | 0.3047 |
| June 30, 2019 | 0.2011 |
| March 31, 2019 | 0.1575 |
| December 31, 2018 | 0.1285 |
| September 30, 2018 | 0.1091 |
| June 30, 2018 | 0.1652 |
| March 31, 2018 | 0.135 |
| December 31, 2017 | 0.1584 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.1318 |
| June 30, 2017 | 0.1129 |
| March 31, 2017 | 0.2374 |
| December 31, 2016 | 0.1902 |
| September 30, 2016 | 0.1601 |
| June 30, 2016 | 0.1434 |
| March 31, 2016 | 0.1714 |
| December 31, 2015 | 0.2033 |
| September 30, 2015 | 0.3579 |
| June 30, 2015 | 0.4305 |
| March 31, 2015 | 0.3543 |
| December 31, 2014 | 0.2546 |
| September 30, 2014 | 0.2624 |
| June 30, 2014 | 0.2324 |
| March 31, 2014 | 0.1791 |
| December 31, 2013 | 0.1929 |
| September 30, 2013 | 0.1577 |
| June 30, 2013 | 0.1296 |
| March 31, 2013 | 0.12 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.022 |
| June 30, 2012 | 0.0193 |
| March 31, 2012 | 0.0172 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.014 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
3.469
Maximum
Jun 2021
1.071
Average
1.168
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Integer Holdings Corp | 0.6319 |
| Cerus Corp | 1.516 |
| Axogen Inc | 0.4871 |
| AVITA Medical Inc | 0.8116 |
| Intellia Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.746B |
| Total Liabilities (Quarterly) | 1.045B |
| Shareholders Equity (Quarterly) | 701.30M |
| Current Ratio | 7.809 |
| Net Debt Paydown Yield | 0.03% |